The most common causes of hospitalisation and death in patients with diabetes – results of the National Diabetology Registry

Česká verzia

Authors: Kvapil M. ¹; Benešová K. ^2,3; Jarkovský J. ^2,3; Dušek L. ^2,3
Authors place of work: Interní klinika 2. LF UK a FN Motol ¹; Ústav zdravotnických informací a statistiky ČR, Praha ²; Institut biostatistiky a analýz, LF MU Brno ³
Published in the journal: Kardiol Rev Int Med 2019, 21(1): 5-6

Summary

The National Diabetology Registry provides accurate statistics of the main causes of death and the causes of hospitalisation in patients with diabetes mellitus. According to a recent data analysis, mortality in some groups of diabetic patients and mortality from vascular disease has been decreasing, while mortality from malignant disease has been increasing. These trends require establishing new priorities for Czech diabetology.

Keywords:

diabetes mellitus – mortality – hospitalisation

Zdroje

1. Bartášková D, Kožnarová R, Kvapil M. Analýza farmakoekonomických aspektů léčby diabetes mellitus v České republice. Remedia 2004;14(4): 377– 384.

2. Dolezal T, Písaríková Z, Zemanová P et al. Costs of type II diabetes in the conditions of the Czech Republic's medical care system. Vnitr Lek 2009; 55(4): 342– 344.

3. Kvapil M. Realistic possibilities of using data sources in quality assessment of care of patients with diabetes in the Czech Republic: National Diabetes Information System. Vnitr Lek 2015; 61 (11 Suppl 3):3S10– 3S13.

4. Brož J, Honěk P, Dušek L et al. The mortality of patients with diabetes mellitus using oral antidiabetic drugs in the Czech Republic decreased over the decade of 2003-2013 and came closer to the population average. Vnitr Lek 2015; 61 (11 Suppl 3): 3S14– 3S20.

5. Tsujimoto T, Kajio H, Sugiyama T. Favourable changes in mortality in people with diabetes: US NHANES 1999-2010. Diabetes Obes Metab 2018; 20(1): 85– 93. doi: 10.1111/ dom.13039.

6. Green A, Sortsø C, Jensen PB et al. Incidence, morbidity, mortality, and prevalence of diabetes in Denmark, 2000-2011: results from the Diabetes Impact Study 2013. Clin Epidemiol 2015; 7: 421– 430. doi: 10.2147/ CLEP.S88577

7. Bruthans J, Bruthansová D. Kardiovaskulární revoluce. Demografie 2009; 51(3): 182– 189.

8. Noto H, Goto A, Tsujimoto T et al. Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis. PLoS One 2012; 7(3): e33411. doi: 10.1371/ journal.pone.0033411.